Marinescu Daniel-Costin, Wong Alyson W, Shah Aditi, Hague Cameron J, Murphy Darra, Yang Julia, Johnston James, Leung Janice, Carlsten Christopher, Ryerson Christopher J
Division of Respiratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
Centre for Lung Health, Vancouver, British Columbia, Canada.
BMJ Open Respir Res. 2025 Jan 19;12(1):e002725. doi: 10.1136/bmjresp-2024-002725.
Persistent lung abnormalities following COVID-19 infection are common. Similar parenchymal changes are observed in idiopathic pulmonary fibrosis (IPF). We investigated whether common genetic risk factors in IPF are associated with developing lung parenchymal abnormalities following severe COVID-19 disease.
Consecutive adults hospitalised for laboratory-confirmed COVID-19 infection were prospectively recruited from March to May 2020. Three single-nucleotide polymorphisms (SNPs) conferring risk for IPF were genotyped ( rs35705950 rs1278769 and rs12610495). High-resolution CT and pulmonary function tests were performed at 3 months postdischarge from hospital. Ground glass opacities and reticulation on imaging were visually quantified by two expert thoracic radiologists. Linear regression was used to evaluate the association between risk alleles at each of the three SNPs and (a) lung parenchymal abnormalities as well as (b) pulmonary function, adjusted for age, sex, smoking history and days spent on supplemental oxygen during acute illness.
71 patients were included. Mean age was 63±16 years, 62% were male, 31% were ever-smokers and median hospital length of stay was 9±11 days, with 23% requiring mechanical ventilation. The risk allele was associated with a significant decrease in ground glass (β=-0.8, 95% CI -1.5 to -0.1, p=0.02) at 3 months, and this finding was paralleled by a concurrent but non-significant trend towards increased diffusion capacity for carbon monoxide (DLCO) (β=8.8, 95% CI -1.2 to 18.8, p=0.08) compared with patients without this risk allele. None of the risk alleles were significantly associated with reticulation at 3 months.
In an adjusted analysis controlling for severity of infection, was associated with reduced ground glass and a trend towards concordant higher DLCO at 3 months after severe COVID-19 illness. This hypothesis-generating result suggests a possible protective effect of in postinfectious lung abnormalities as compared with fibrosis in IPF, highlighting a plausible trade-off between its role in immune defence and epithelial cell function.
新型冠状病毒肺炎(COVID-19)感染后持续存在的肺部异常很常见。在特发性肺纤维化(IPF)中也观察到类似的实质改变。我们研究了IPF中常见的遗传风险因素是否与重症COVID-19疾病后发生的肺实质异常有关。
2020年3月至5月前瞻性招募因实验室确诊的COVID-19感染而住院的连续成年患者。对赋予IPF风险的三个单核苷酸多态性(SNP)进行基因分型(rs35705950、rs1278769和rs12610495)。出院后3个月进行高分辨率CT和肺功能测试。由两位胸科放射学专家对影像学上的磨玻璃影和网状影进行视觉量化。采用线性回归评估三个SNP中每个SNP的风险等位基因与(a)肺实质异常以及(b)肺功能之间的关联,并对年龄、性别、吸烟史和急性疾病期间使用补充氧气的天数进行校正。
纳入71例患者。平均年龄为63±16岁,62%为男性,31%为曾经吸烟者,中位住院时间为9±11天,23%需要机械通气。该风险等位基因与3个月时磨玻璃影显著减少相关(β=-0.8,95%CI -1.5至-0.1,p=0.02),与无该风险等位基因的患者相比,同时一氧化碳弥散量(DLCO)有增加的趋势但不显著(β=8.8,95%CI -1.2至18.8,p=0.08)。3个月时,没有一个风险等位基因与网状影显著相关。
在控制感染严重程度的校正分析中,该基因与重症COVID-19疾病后3个月时磨玻璃影减少以及DLCO升高的趋势相关。这一产生假设的结果表明,与IPF中的纤维化相比,该基因在感染后肺部异常中可能具有保护作用,突出了其在免疫防御和上皮细胞功能中的作用之间可能存在的权衡。